| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 2.20e-14 | 38 | 79 | 9 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH1 MYH2 MYH3 MYH4 DNAH3 MYH7 MYH8 MYH10 MYH13 DNAH10 MYH7B | 1.23e-12 | 118 | 79 | 11 | GO:0003774 |
| GeneOntologyMolecularFunction | actin filament binding | SPTBN4 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B SYNE1 SPTBN1 MACF1 | 5.11e-12 | 227 | 79 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 SPTBN1 SCN5A MAPKAPK5 RYR1 | 1.06e-10 | 230 | 79 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH3 MYH4 DNAH3 ATP6V1C1 MYH7 MYH8 MYH10 MYH13 DNAH10 MYH7B SMC1A SMARCA1 MLH1 MACF1 ATP1A1 | 2.14e-10 | 614 | 79 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | actin binding | SPTBN4 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B SYNE1 SPTBN1 MACF1 | 4.62e-08 | 479 | 79 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ROCK2 SPTBN4 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B SYNE1 SPTBN1 SCN5A MACF1 SNAP25 ATP1A1 DCTN1 | 2.11e-07 | 1099 | 79 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | ankyrin binding | 1.90e-06 | 23 | 79 | 4 | GO:0030506 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 9.22e-06 | 441 | 79 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | GTPBP4 MYH3 MYH4 DNAH3 MYH7 MYH8 DNAH10 SMC1A MLH1 MACF1 RASEF ATP1A1 | 5.04e-05 | 775 | 79 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | GTPBP4 MYH3 MYH4 DNAH3 MYH7 MYH8 DNAH10 SMC1A MLH1 MACF1 RASEF ATP1A1 | 1.07e-04 | 839 | 79 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | GTPBP4 MYH3 MYH4 DNAH3 MYH7 MYH8 DNAH10 SMC1A MLH1 MACF1 RASEF ATP1A1 | 1.09e-04 | 840 | 79 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | GTPBP4 MYH3 MYH4 DNAH3 MYH7 MYH8 DNAH10 SMC1A MLH1 MACF1 RASEF ATP1A1 | 1.09e-04 | 840 | 79 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 8.31e-04 | 11 | 79 | 2 | GO:0019870 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.69e-10 | 153 | 77 | 10 | GO:0030048 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.08e-09 | 127 | 77 | 9 | GO:0070252 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 1.85e-09 | 15 | 77 | 5 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 5.24e-09 | 18 | 77 | 5 | GO:0033275 | |
| GeneOntologyBiologicalProcess | muscle contraction | ROCK2 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH13 MYH7B SCN5A ATP1A1 RYR1 | 2.83e-08 | 400 | 77 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | muscle system process | ROCK2 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH13 MYH7B SCN5A ATP1A1 OGA RYR1 | 1.08e-07 | 547 | 77 | 13 | GO:0003012 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.67e-05 | 217 | 77 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ROCK2 SPTBN4 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH7B SPTBN1 SCN5A ATP1A1 ZEB2 | 3.01e-05 | 912 | 77 | 13 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 3.81e-05 | 101 | 77 | 5 | GO:0002028 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 4.58e-05 | 53 | 77 | 4 | GO:1903115 | |
| GeneOntologyBiologicalProcess | regulation of system process | ROCK2 SPTBN4 MYH7 MYH7B SYNE1 SCN5A FGFR4 ATP1A1 OGA WNK3 RYR1 | 8.46e-05 | 734 | 77 | 11 | GO:0044057 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 1.76e-04 | 422 | 77 | 8 | GO:1990778 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 1.82e-04 | 317 | 77 | 7 | GO:0090257 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 1.96e-04 | 225 | 77 | 6 | GO:0050905 | |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | 2.08e-04 | 324 | 77 | 7 | GO:0072659 | |
| GeneOntologyBiologicalProcess | nuclear migration | 2.75e-04 | 34 | 77 | 3 | GO:0007097 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | ROCK2 PIKFYVE SPTBN4 SPTBN1 MACF1 SNAP25 OGA WNK3 GOLGA4 NGDN | 2.84e-04 | 705 | 77 | 10 | GO:0072657 |
| GeneOntologyBiologicalProcess | positive regulation of potassium ion import across plasma membrane | 2.85e-04 | 7 | 77 | 2 | GO:1903288 | |
| GeneOntologyBiologicalProcess | osmosensory signaling pathway | 3.80e-04 | 8 | 77 | 2 | GO:0007231 | |
| GeneOntologyBiologicalProcess | response to DNA damage checkpoint signaling | 3.80e-04 | 8 | 77 | 2 | GO:0072423 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 3.90e-04 | 475 | 77 | 8 | GO:0140694 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion import | 4.87e-04 | 9 | 77 | 2 | GO:1903286 | |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transport | 5.17e-04 | 42 | 77 | 3 | GO:0010765 | |
| GeneOntologyBiologicalProcess | positive regulation of potassium ion transmembrane transport | 5.17e-04 | 42 | 77 | 3 | GO:1901381 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 5.54e-04 | 43 | 77 | 3 | GO:0086004 | |
| GeneOntologyBiologicalProcess | nucleus localization | 5.93e-04 | 44 | 77 | 3 | GO:0051647 | |
| GeneOntologyBiologicalProcess | response to cell cycle checkpoint signaling | 6.07e-04 | 10 | 77 | 2 | GO:0072396 | |
| GeneOntologyBiologicalProcess | response to DNA integrity checkpoint signaling | 6.07e-04 | 10 | 77 | 2 | GO:0072402 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane protein transport | 6.34e-04 | 45 | 77 | 3 | GO:0043001 | |
| GeneOntologyCellularComponent | myosin filament | 1.69e-16 | 25 | 78 | 9 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 5.68e-16 | 28 | 78 | 9 | GO:0016460 | |
| GeneOntologyCellularComponent | muscle myosin complex | 8.51e-14 | 16 | 78 | 7 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 9.42e-13 | 59 | 78 | 9 | GO:0016459 | |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH13 MYH7B SYNE1 SPTBN1 SCN5A PGM1 RYR1 | 2.50e-11 | 273 | 78 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH13 MYH7B SYNE1 SPTBN1 SCN5A PGM1 RYR1 | 5.31e-11 | 290 | 78 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | 2.11e-09 | 249 | 78 | 11 | GO:0030017 | |
| GeneOntologyCellularComponent | supramolecular fiber | CEP170 SPTBN4 MYH1 MYH2 MYH3 MYH4 DNAH3 MYH7 MYH8 MYH10 MYH13 DNAH10 MYH7B SYNE1 SPTBN1 SCN5A MACF1 DCTN1 PGM1 RYR1 | 7.80e-09 | 1179 | 78 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CEP170 SPTBN4 MYH1 MYH2 MYH3 MYH4 DNAH3 MYH7 MYH8 MYH10 MYH13 DNAH10 MYH7B SYNE1 SPTBN1 SCN5A MACF1 DCTN1 PGM1 RYR1 | 8.74e-09 | 1187 | 78 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | SPTBN4 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MPP4 MYH7B SPTBN1 MACF1 SNAP25 | 2.52e-08 | 576 | 78 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | cell cortex | 7.25e-05 | 371 | 78 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | intercalated disc | 1.22e-04 | 68 | 78 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | ERCC4-ERCC1 complex | 1.36e-04 | 5 | 78 | 2 | GO:0070522 | |
| GeneOntologyCellularComponent | T-tubule | 2.18e-04 | 79 | 78 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | cell-cell junction | 3.49e-04 | 591 | 78 | 9 | GO:0005911 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 3.59e-04 | 90 | 78 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 4.24e-04 | 94 | 78 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | spectrin | 4.86e-04 | 9 | 78 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | inner dynein arm | 6.07e-04 | 10 | 78 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 6.07e-04 | 10 | 78 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | A band | 9.68e-04 | 52 | 78 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | nucleotide-excision repair complex | 1.04e-03 | 13 | 78 | 2 | GO:0000109 | |
| GeneOntologyCellularComponent | dynein complex | 1.08e-03 | 54 | 78 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | axon | DAB2IP SPTBN4 MYH10 MPP4 SPTBN1 SCN5A SNAP25 ATP1A1 DCTN1 NGDN | 1.71e-03 | 891 | 78 | 10 | GO:0030424 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | PIKFYVE GTPBP4 SYNE1 RASGRP3 SCN5A RASEF SNAP25 HEATR5B ZFYVE1 RYR1 | 2.42e-03 | 934 | 78 | 10 | GO:0048471 |
| GeneOntologyCellularComponent | Z disc | 2.47e-03 | 151 | 78 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 3.11e-03 | 78 | 78 | 3 | GO:0001917 | |
| GeneOntologyCellularComponent | anchoring junction | 3.32e-03 | 976 | 78 | 10 | GO:0070161 | |
| GeneOntologyCellularComponent | I band | 3.47e-03 | 166 | 78 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.90e-03 | 25 | 78 | 2 | GO:0005858 | |
| HumanPheno | Malignant hyperthermia | 1.97e-05 | 26 | 33 | 4 | HP:0002047 | |
| HumanPheno | Lower extremity joint dislocation | 1.99e-05 | 318 | 33 | 10 | HP:0030311 | |
| HumanPheno | Delayed gross motor development | SPTBN4 MYH7 TMTC3 SYNE1 SMC1A MACF1 ZNF407 FASTKD2 SNAP25 ATP1A1 ZEB2 RYR1 | 2.44e-05 | 481 | 33 | 12 | HP:0002194 |
| HumanPheno | Mask-like facies | 5.79e-05 | 109 | 33 | 6 | HP:0000298 | |
| HumanPheno | Muscle fiber atrophy | 6.04e-05 | 67 | 33 | 5 | HP:0100295 | |
| HumanPheno | Delayed ability to walk | 9.19e-05 | 304 | 33 | 9 | HP:0031936 | |
| HumanPheno | Joint dislocation | 1.15e-04 | 390 | 33 | 10 | HP:0001373 | |
| Domain | Myosin_N | 1.18e-18 | 15 | 78 | 9 | PF02736 | |
| Domain | Myosin_N | 1.18e-18 | 15 | 78 | 9 | IPR004009 | |
| Domain | Myosin_tail_1 | 1.13e-17 | 18 | 78 | 9 | PF01576 | |
| Domain | Myosin_tail | 1.13e-17 | 18 | 78 | 9 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 2.14e-17 | 19 | 78 | 9 | IPR027401 | |
| Domain | - | 2.14e-17 | 19 | 78 | 9 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 3.55e-14 | 38 | 78 | 9 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.55e-14 | 38 | 78 | 9 | PS51456 | |
| Domain | Myosin_head | 3.55e-14 | 38 | 78 | 9 | PF00063 | |
| Domain | MYSc | 3.55e-14 | 38 | 78 | 9 | SM00242 | |
| Domain | IQ | 1.32e-12 | 81 | 78 | 10 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 3.89e-12 | 90 | 78 | 10 | IPR000048 | |
| Domain | IQ | 5.44e-12 | 93 | 78 | 10 | PS50096 | |
| Domain | IQ | 1.81e-08 | 71 | 78 | 7 | PF00612 | |
| Domain | P-loop_NTPase | GTPBP4 MYH1 MYH2 MYH3 MYH4 DNAH3 MYH7 MYH8 MYH10 MYH13 DNAH10 MPP4 MYH7B SMC1A SMARCA1 RASEF ZFYVE1 | 5.84e-08 | 848 | 78 | 17 | IPR027417 |
| Domain | Actinin_actin-bd_CS | 2.35e-06 | 23 | 78 | 4 | IPR001589 | |
| Domain | Spectrin | 2.35e-06 | 23 | 78 | 4 | PF00435 | |
| Domain | ACTININ_2 | 2.35e-06 | 23 | 78 | 4 | PS00020 | |
| Domain | ACTININ_1 | 2.35e-06 | 23 | 78 | 4 | PS00019 | |
| Domain | Spectrin_repeat | 6.17e-06 | 29 | 78 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 9.26e-06 | 32 | 78 | 4 | IPR018159 | |
| Domain | SPEC | 9.26e-06 | 32 | 78 | 4 | SM00150 | |
| Domain | EFh | 5.18e-05 | 158 | 78 | 6 | SM00054 | |
| Domain | EF_hand_dom | 5.21e-05 | 232 | 78 | 7 | IPR002048 | |
| Domain | EF_Hand_1_Ca_BS | 9.13e-05 | 175 | 78 | 6 | IPR018247 | |
| Domain | Spectrin_bsu | 1.03e-04 | 4 | 78 | 2 | IPR016343 | |
| Domain | - | 1.09e-04 | 261 | 78 | 7 | 1.10.238.10 | |
| Domain | CH | 1.57e-04 | 65 | 78 | 4 | SM00033 | |
| Domain | EF-hand-dom_pair | 1.96e-04 | 287 | 78 | 7 | IPR011992 | |
| Domain | CH | 2.09e-04 | 70 | 78 | 4 | PF00307 | |
| Domain | EF_HAND_1 | 2.11e-04 | 204 | 78 | 6 | PS00018 | |
| Domain | - | 2.21e-04 | 71 | 78 | 4 | 1.10.418.10 | |
| Domain | CH | 2.46e-04 | 73 | 78 | 4 | PS50021 | |
| Domain | Kinase_OSR1/WNK_CCT | 2.55e-04 | 6 | 78 | 2 | IPR024678 | |
| Domain | OSR1_C | 2.55e-04 | 6 | 78 | 2 | PF12202 | |
| Domain | CH-domain | 2.73e-04 | 75 | 78 | 4 | IPR001715 | |
| Domain | EF_HAND_2 | 4.10e-04 | 231 | 78 | 6 | PS50222 | |
| Domain | PH_dom-spectrin-type | 6.08e-04 | 9 | 78 | 2 | IPR001605 | |
| Domain | SANT | 1.19e-03 | 50 | 78 | 3 | SM00717 | |
| Domain | SANT/Myb | 1.34e-03 | 52 | 78 | 3 | IPR001005 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.52e-03 | 14 | 78 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.52e-03 | 14 | 78 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.52e-03 | 14 | 78 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.52e-03 | 14 | 78 | 2 | PF08393 | |
| Domain | MT | 1.52e-03 | 14 | 78 | 2 | PF12777 | |
| Domain | AAA_8 | 1.52e-03 | 14 | 78 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.52e-03 | 14 | 78 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.52e-03 | 14 | 78 | 2 | PF07728 | |
| Domain | DHC_fam | 1.75e-03 | 15 | 78 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.75e-03 | 15 | 78 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.75e-03 | 15 | 78 | 2 | PF03028 | |
| Domain | EF-hand_1 | 3.77e-03 | 152 | 78 | 4 | PF00036 | |
| Domain | EF-hand_5 | 4.85e-03 | 25 | 78 | 2 | PF13202 | |
| Domain | EF-hand_7 | 5.41e-03 | 85 | 78 | 3 | PF13499 | |
| Domain | FHA | 6.07e-03 | 28 | 78 | 2 | SM00240 | |
| Domain | FYVE | 6.50e-03 | 29 | 78 | 2 | PF01363 | |
| Domain | FYVE | 6.50e-03 | 29 | 78 | 2 | SM00064 | |
| Domain | FHA_DOMAIN | 7.40e-03 | 31 | 78 | 2 | PS50006 | |
| Domain | FHA | 7.40e-03 | 31 | 78 | 2 | PF00498 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 9.46e-12 | 70 | 58 | 9 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 3.04e-09 | 132 | 58 | 9 | M11355 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.80e-04 | 27 | 58 | 3 | M47755 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.74e-04 | 31 | 58 | 3 | M877 | |
| Pubmed | 2.38e-19 | 7 | 79 | 7 | 35210422 | ||
| Pubmed | 1.13e-16 | 6 | 79 | 6 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.13e-16 | 6 | 79 | 6 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.13e-16 | 6 | 79 | 6 | 10588881 | |
| Pubmed | ROCK2 SPTBN4 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 SFPQ MYH13 ZBED4 ZNF608 MYH7B SYNE1 SPTBN1 SMARCA1 MACF1 ATP1A1 DCTN1 ERBIN ZEB2 THRAP3 ESF1 NGDN | 6.53e-16 | 1442 | 79 | 25 | 35575683 | |
| Pubmed | 7.91e-16 | 7 | 79 | 6 | 16819597 | ||
| Pubmed | 5.32e-14 | 5 | 79 | 5 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 5.32e-14 | 5 | 79 | 5 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 5.32e-14 | 5 | 79 | 5 | 12919077 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.92e-13 | 13 | 79 | 6 | 8404542 | |
| Pubmed | 3.35e-13 | 14 | 79 | 6 | 27184118 | ||
| Pubmed | CEP170 ZNF462 MYH3 MYH7 MYH8 SFPQ SYNE1 SMC1A SPTBN1 MACF1 ZNF407 ATP1A1 DCTN1 PGM1 RYR1 | 4.01e-13 | 497 | 79 | 15 | 23414517 | |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 9.68e-13 | 33 | 79 | 7 | 32094117 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.11e-12 | 7 | 79 | 5 | 29758057 | |
| Pubmed | 2.96e-12 | 8 | 79 | 5 | 3864153 | ||
| Pubmed | DAB2IP CEP170 ROCK2 ZNF462 SPTBN4 GTPBP4 MYH10 SFPQ SYNE1 SPTBN1 MACF1 DCTN1 ERBIN ZEB2 THRAP3 WNK3 GOLGA4 WNK2 | 4.40e-12 | 963 | 79 | 18 | 28671696 | |
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 2.43e-11 | 11 | 79 | 5 | 16024798 | |
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 10388558 | ||
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 20357587 | ||
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 1985022 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 1.57e-10 | 15 | 79 | 5 | 24852826 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 2.28e-10 | 16 | 79 | 5 | 19922871 | |
| Pubmed | 3.22e-10 | 17 | 79 | 5 | 16124007 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 9.86e-10 | 46 | 79 | 6 | 28827394 | |
| Pubmed | 1.36e-09 | 22 | 79 | 5 | 24301466 | ||
| Pubmed | 1.71e-09 | 8 | 79 | 4 | 26993635 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CEP170 ZNF462 GTPBP4 SNRNP27 CAAP1 MYH10 SFPQ PAXBP1 ZBED4 SYNE1 SMC1A VCAN SPTBN1 MACF1 USP9Y THRAP3 | 2.37e-09 | 1082 | 79 | 16 | 38697112 |
| Pubmed | 3.08e-09 | 9 | 79 | 4 | 31960486 | ||
| Pubmed | 4.17e-09 | 58 | 79 | 6 | 21884692 | ||
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 5.12e-09 | 10 | 79 | 4 | 2211821 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 5.12e-09 | 10 | 79 | 4 | 8950513 | |
| Pubmed | 8.04e-09 | 11 | 79 | 4 | 18310078 | ||
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 8.04e-09 | 11 | 79 | 4 | 29168801 | |
| Pubmed | 8.04e-09 | 11 | 79 | 4 | 8136524 | ||
| Pubmed | 8.63e-09 | 31 | 79 | 5 | 21985497 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.13e-08 | 3 | 79 | 3 | 26059207 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 36515178 | ||
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 1.13e-08 | 3 | 79 | 3 | 1371481 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 25567808 | ||
| Pubmed | Identification of three developmentally controlled isoforms of human myosin heavy chains. | 1.13e-08 | 3 | 79 | 3 | 1691980 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 21470888 | ||
| Pubmed | 1.74e-08 | 13 | 79 | 4 | 8948582 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 24938781 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 33742095 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B SPTBN1 RASEF DCTN1 | 2.55e-08 | 647 | 79 | 12 | 26618866 |
| Pubmed | 2.88e-08 | 39 | 79 | 5 | 38690566 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ROCK2 HMGN5 GTPBP4 SFPQ SYNE1 SMC1A SPTBN1 MACF1 FASTKD2 THRAP3 ESF1 NOL8 NGDN | 3.31e-08 | 807 | 79 | 13 | 22681889 |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 11023856 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 4.50e-08 | 4 | 79 | 3 | 11029314 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 19948655 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 4.50e-08 | 4 | 79 | 3 | 18417546 | |
| Pubmed | 4.76e-08 | 225 | 79 | 8 | 12168954 | ||
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 5.74e-08 | 17 | 79 | 4 | 22351927 | |
| Pubmed | 1.10e-07 | 251 | 79 | 8 | 27507650 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.12e-07 | 5 | 79 | 3 | 30737693 | |
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 6879174 | ||
| Pubmed | Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. | 1.12e-07 | 5 | 79 | 3 | 17584907 | |
| Pubmed | CEP170 ROCK2 SPTBN4 ATP6V1C1 MYH10 SFPQ SYNE1 VCAN SPTBN1 MACF1 ATP1A1 DCTN1 ERBIN THRAP3 WNK2 PGM1 | 1.16e-07 | 1431 | 79 | 16 | 37142655 | |
| Pubmed | 1.16e-07 | 20 | 79 | 4 | 21689717 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CEP170 MYH1 MYH2 MYH3 MYH7 MYH8 MYH13 FGFR4 MAPKAPK5 DCTN1 THRAP3 ESF1 AKAP7 | 1.33e-07 | 910 | 79 | 13 | 36736316 |
| Pubmed | DAB2IP TCEA1 SFPQ PAXBP1 VCAN SPTBN1 MACF1 ZFYVE1 DCTN1 ERBIN QSOX2 SLX4 PGM1 ESF1 | 1.42e-07 | 1084 | 79 | 14 | 11544199 | |
| Pubmed | 1.75e-07 | 22 | 79 | 4 | 37468485 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ROCK2 TCEA1 CAAP1 PAXBP1 SLC4A1AP SMC1A SPTBN1 OGA ERBIN THRAP3 GOLGA4 ESF1 | 1.78e-07 | 774 | 79 | 12 | 15302935 |
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 10444070 | ||
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 2.24e-07 | 6 | 79 | 3 | 17559643 | |
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 30695685 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | CEP170 TCEA1 MYH7 MYH10 SFPQ SMC1A SPTBN1 MACF1 ATP1A1 XRCC4 OGA DCTN1 PGM1 ESF1 | 2.87e-07 | 1149 | 79 | 14 | 35446349 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.37e-07 | 120 | 79 | 6 | 31413325 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GTPBP4 MYH10 SFPQ SMC1A SPTBN1 SMARCA1 MLH1 MACF1 FASTKD2 DCTN1 ERBIN THRAP3 GOLGA4 ESF1 NGDN | 3.40e-07 | 1353 | 79 | 15 | 29467282 |
| Pubmed | The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion. | 3.92e-07 | 7 | 79 | 3 | 26586200 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ROCK2 GTPBP4 DNAH3 MYH10 SFPQ MYH13 SLC4A1AP SMC1A SPTBN1 MACF1 DCTN1 THRAP3 | 4.63e-07 | 847 | 79 | 12 | 35235311 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CEP170 ROCK2 GTPBP4 MYH10 SFPQ PAXBP1 EAPP SLC4A1AP SMC1A SPTBN1 MACF1 ATP1A1 DCTN1 THRAP3 GOLGA4 | 5.99e-07 | 1415 | 79 | 15 | 28515276 |
| Pubmed | 6.27e-07 | 8 | 79 | 3 | 36200826 | ||
| Pubmed | 6.27e-07 | 8 | 79 | 3 | 33667029 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 6.27e-07 | 8 | 79 | 3 | 14667415 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GTPBP4 MYH10 SFPQ PAXBP1 DNAH10 SYNE1 SMC1A SPTBN1 SMARCA1 FASTKD2 ATP1A1 DCTN1 THRAP3 GOLGA4 ESF1 | 6.54e-07 | 1425 | 79 | 15 | 30948266 |
| Pubmed | 7.40e-07 | 31 | 79 | 4 | 30081710 | ||
| Pubmed | ROCK2 GTPBP4 MYH10 SFPQ PAXBP1 ZNF608 SMC1A SPTBN1 MLH1 ATP1A1 DCTN1 ERBIN THRAP3 ESF1 | 7.62e-07 | 1247 | 79 | 14 | 27684187 | |
| Pubmed | 8.45e-07 | 32 | 79 | 4 | 33732701 | ||
| Pubmed | 8.97e-07 | 331 | 79 | 8 | 29199018 | ||
| Pubmed | Muscle-specific gene expression during myogenesis in the mouse. | 9.38e-07 | 9 | 79 | 3 | 7787235 | |
| Pubmed | GTPBP4 PAXBP1 EAPP TMTC3 SLC4A1AP SYNE1 SPTBN1 MACF1 FASTKD2 OGA DCTN1 ERBIN GOLGA4 ESF1 NOL8 | 1.11e-06 | 1487 | 79 | 15 | 33957083 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CEP170 GTPBP4 MYH10 SFPQ MLH1 MACF1 ATP1A1 OGA DCTN1 ERBIN ESF1 NOL8 | 1.29e-06 | 934 | 79 | 12 | 33916271 |
| Pubmed | 1.30e-06 | 151 | 79 | 6 | 17043677 | ||
| Pubmed | 1.34e-06 | 10 | 79 | 3 | 19506036 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CEP170 TCEA1 CAAP1 SFPQ PAXBP1 SLC4A1AP SMC1A SAP130 THRAP3 SLX4 ESF1 NOL8 | 1.60e-06 | 954 | 79 | 12 | 36373674 |
| Pubmed | 1.63e-06 | 486 | 79 | 9 | 20936779 | ||
| Pubmed | 1.70e-06 | 250 | 79 | 7 | 33536335 | ||
| Pubmed | 1.84e-06 | 493 | 79 | 9 | 15368895 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.84e-06 | 11 | 79 | 3 | 38303699 | |
| Pubmed | 1.84e-06 | 11 | 79 | 3 | 30962377 | ||
| Pubmed | 1.84e-06 | 11 | 79 | 3 | 26644518 | ||
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 1.84e-06 | 11 | 79 | 3 | 39256359 | |
| Pubmed | The FgfrL1 receptor is required for development of slow muscle fibers. | 1.84e-06 | 11 | 79 | 3 | 25172430 | |
| Pubmed | 2.27e-06 | 506 | 79 | 9 | 30890647 | ||
| Pubmed | 2.45e-06 | 12 | 79 | 3 | 8424456 | ||
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 2.45e-06 | 12 | 79 | 3 | 28600496 | |
| Pubmed | 3.12e-06 | 274 | 79 | 7 | 34244482 | ||
| Pubmed | Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. | 3.17e-06 | 13 | 79 | 3 | 10694423 | |
| Interaction | ASAH2 interactions | 3.26e-09 | 6 | 79 | 4 | int:ASAH2 | |
| Interaction | RSPH6A interactions | 3.69e-09 | 34 | 79 | 6 | int:RSPH6A | |
| Interaction | TMEM260 interactions | 1.52e-07 | 13 | 79 | 4 | int:TMEM260 | |
| Interaction | TSPAN33 interactions | 2.06e-07 | 65 | 79 | 6 | int:TSPAN33 | |
| Interaction | PRKAG2 interactions | 2.70e-07 | 68 | 79 | 6 | int:PRKAG2 | |
| Interaction | ACTN2 interactions | 3.56e-07 | 171 | 79 | 8 | int:ACTN2 | |
| Interaction | KIF20A interactions | CEP170 ZNF462 SPTBN4 GTPBP4 MYH10 SFPQ PAXBP1 SYNE1 SPTBN1 SMARCA1 MACF1 USP9Y DCTN1 SAP130 ERBIN ZEB2 THRAP3 | 5.19e-07 | 1052 | 79 | 17 | int:KIF20A |
| Interaction | MECP2 interactions | CEP170 ZNF462 GTPBP4 SNRNP27 CAAP1 MYH10 SFPQ PAXBP1 ZBED4 SYNE1 SMC1A VCAN SPTBN1 MACF1 USP9Y THRAP3 ESF1 NOL8 | 1.83e-06 | 1287 | 79 | 18 | int:MECP2 |
| Interaction | TLE3 interactions | 2.08e-06 | 376 | 79 | 10 | int:TLE3 | |
| Interaction | TNIK interactions | CEP170 ZNF462 GTPBP4 SYNE1 SPTBN1 MACF1 FGFR4 ZEB2 THRAP3 GOLGA4 | 2.34e-06 | 381 | 79 | 10 | int:TNIK |
| Interaction | CFAP141 interactions | 2.43e-06 | 55 | 79 | 5 | int:CFAP141 | |
| Interaction | ABTB2 interactions | 2.82e-06 | 101 | 79 | 6 | int:ABTB2 | |
| Interaction | CFTR interactions | CEP170 ZNF462 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 SFPQ MYH13 MYH7B SPTBN1 MACF1 RASEF FASTKD2 ATP1A1 DCTN1 ERBIN | 3.17e-06 | 1480 | 79 | 19 | int:CFTR |
| Interaction | SNAPIN interactions | 4.49e-06 | 169 | 79 | 7 | int:SNAPIN | |
| Interaction | CDK3 interactions | 5.70e-06 | 114 | 79 | 6 | int:CDK3 | |
| Interaction | STK3 interactions | 7.06e-06 | 181 | 79 | 7 | int:STK3 | |
| Interaction | SBDS interactions | 7.06e-06 | 181 | 79 | 7 | int:SBDS | |
| Interaction | SLC39A3 interactions | 8.07e-06 | 70 | 79 | 5 | int:SLC39A3 | |
| Interaction | TPM1 interactions | 8.86e-06 | 263 | 79 | 8 | int:TPM1 | |
| Interaction | SNRNP200 interactions | PIKFYVE TCEA1 SFPQ PAXBP1 EAPP SMC1A ATP1A1 XRCC4 THRAP3 SLX4 | 1.23e-05 | 460 | 79 | 10 | int:SNRNP200 |
| Interaction | ZSCAN5A interactions | 1.46e-05 | 38 | 79 | 4 | int:ZSCAN5A | |
| Interaction | ACTC1 interactions | GTPBP4 MYH10 SFPQ PAXBP1 SLC4A1AP SYNE1 SPTBN1 DCTN1 THRAP3 SLX4 WNK2 ESF1 | 1.57e-05 | 694 | 79 | 12 | int:ACTC1 |
| Interaction | LACTB2 interactions | 1.75e-05 | 82 | 79 | 5 | int:LACTB2 | |
| Interaction | DDX23 interactions | 1.77e-05 | 480 | 79 | 10 | int:DDX23 | |
| Interaction | FBXO32 interactions | 1.99e-05 | 386 | 79 | 9 | int:FBXO32 | |
| Interaction | AURKC interactions | 2.40e-05 | 43 | 79 | 4 | int:AURKC | |
| Interaction | HECTD1 interactions | CEP170 GTPBP4 SNRNP27 MYH10 SFPQ PAXBP1 SMC1A MACF1 XRCC4 DCTN1 SAP130 ESF1 NOL8 NGDN | 2.55e-05 | 984 | 79 | 14 | int:HECTD1 |
| Interaction | CYLD interactions | CEP170 ROCK2 MYH10 SFPQ MYH13 SLC4A1AP SPTBN1 FGFR4 ATP1A1 OGA DCTN1 CALML6 THRAP3 | 3.04e-05 | 868 | 79 | 13 | int:CYLD |
| Interaction | SMC5 interactions | CEP170 TCEA1 MYH1 MYH4 CAAP1 SFPQ PAXBP1 SLC4A1AP SMC1A SAP130 THRAP3 SLX4 ESF1 NOL8 | 3.05e-05 | 1000 | 79 | 14 | int:SMC5 |
| Interaction | HMGN5 interactions | 3.17e-05 | 154 | 79 | 6 | int:HMGN5 | |
| Interaction | MYH6 interactions | 3.40e-05 | 94 | 79 | 5 | int:MYH6 | |
| Interaction | CIT interactions | CEP170 SPTBN4 GTPBP4 SNRNP27 MYH10 SFPQ PAXBP1 SYNE1 SMC1A SPTBN1 SMARCA1 MACF1 ATP1A1 DCTN1 THRAP3 GOLGA4 ESF1 | 3.74e-05 | 1450 | 79 | 17 | int:CIT |
| Interaction | STK4 interactions | 3.79e-05 | 159 | 79 | 6 | int:STK4 | |
| Interaction | SIX1 interactions | 4.05e-05 | 49 | 79 | 4 | int:SIX1 | |
| Interaction | MYH8 interactions | 5.13e-05 | 52 | 79 | 4 | int:MYH8 | |
| Interaction | ZBTB2 interactions | 6.57e-05 | 450 | 79 | 9 | int:ZBTB2 | |
| Interaction | EN1 interactions | 7.23e-05 | 110 | 79 | 5 | int:EN1 | |
| Interaction | LZTR1 interactions | 7.54e-05 | 111 | 79 | 5 | int:LZTR1 | |
| Interaction | SLX4 interactions | 7.78e-05 | 572 | 79 | 10 | int:SLX4 | |
| Interaction | MECOM interactions | 7.98e-05 | 358 | 79 | 8 | int:MECOM | |
| Interaction | CDKL5 interactions | 8.21e-05 | 113 | 79 | 5 | int:CDKL5 | |
| Interaction | KCTD13 interactions | CEP170 ROCK2 SPTBN4 ATP6V1C1 MYH10 SFPQ SYNE1 VCAN SPTBN1 MACF1 ATP1A1 DCTN1 ERBIN THRAP3 WNK2 PGM1 | 8.50e-05 | 1394 | 79 | 16 | int:KCTD13 |
| Interaction | DDX47 interactions | 9.06e-05 | 186 | 79 | 6 | int:DDX47 | |
| Interaction | HDAC1 interactions | MYH1 MYH2 MYH4 MYH7 MYH8 MYH10 SFPQ ZNF608 SMC1A ZFYVE1 DCTN1 SAP130 ZEB2 GOLGA4 | 9.25e-05 | 1108 | 79 | 14 | int:HDAC1 |
| Interaction | NAA40 interactions | CEP170 HMGN5 GTPBP4 MYH10 SFPQ MLH1 MACF1 ATP1A1 OGA DCTN1 ERBIN ESF1 NOL8 | 1.03e-04 | 978 | 79 | 13 | int:NAA40 |
| Interaction | SLFN11 interactions | 1.12e-04 | 376 | 79 | 8 | int:SLFN11 | |
| Interaction | ZNF512B interactions | 1.21e-04 | 196 | 79 | 6 | int:ZNF512B | |
| Interaction | RBSN interactions | 1.23e-04 | 65 | 79 | 4 | int:RBSN | |
| Interaction | BAP1 interactions | CEP170 TCEA1 MYH7 MYH10 SFPQ SMC1A SPTBN1 MACF1 ATP1A1 XRCC4 OGA DCTN1 GOLGA4 PGM1 ESF1 | 1.56e-04 | 1314 | 79 | 15 | int:BAP1 |
| Interaction | SYT3 interactions | 1.58e-04 | 27 | 79 | 3 | int:SYT3 | |
| Interaction | CHD3 interactions | GTPBP4 MYH10 SFPQ PAXBP1 SMC1A SPTBN1 SMARCA1 XRCC4 SAP130 THRAP3 NGDN | 1.72e-04 | 757 | 79 | 11 | int:CHD3 |
| Interaction | KIF23 interactions | CEP170 TCEA1 GTPBP4 MYH10 SFPQ SPTBN1 MACF1 USP9Y HEATR5B THRAP3 SLX4 NOL8 NGDN | 1.73e-04 | 1031 | 79 | 13 | int:KIF23 |
| Interaction | MYH4 interactions | 1.94e-04 | 73 | 79 | 4 | int:MYH4 | |
| Interaction | CCDC69 interactions | 2.18e-04 | 30 | 79 | 3 | int:CCDC69 | |
| Interaction | SMC1A interactions | 2.31e-04 | 418 | 79 | 8 | int:SMC1A | |
| Interaction | SPDL1 interactions | 2.36e-04 | 315 | 79 | 7 | int:SPDL1 | |
| Interaction | S100A4 interactions | 2.56e-04 | 144 | 79 | 5 | int:S100A4 | |
| Interaction | GLDC interactions | 2.65e-04 | 321 | 79 | 7 | int:GLDC | |
| Interaction | NFIX interactions | 2.68e-04 | 227 | 79 | 6 | int:NFIX | |
| Interaction | USP48 interactions | TCEA1 ATP6V1C1 MYH10 SFPQ SPTBN1 SNAP25 ATP1A1 OGA DCTN1 PGM1 | 2.74e-04 | 668 | 79 | 10 | int:USP48 |
| Interaction | TERF2IP interactions | 3.04e-04 | 552 | 79 | 9 | int:TERF2IP | |
| Interaction | BCAP31 interactions | 3.13e-04 | 554 | 79 | 9 | int:BCAP31 | |
| Interaction | LATS1 interactions | 3.26e-04 | 440 | 79 | 8 | int:LATS1 | |
| Interaction | GAPDH interactions | CEP170 MYH7B SMC1A MACF1 SNAP25 DCTN1 SLX4 GOLGA4 RYR1 AKAP7 | 3.39e-04 | 686 | 79 | 10 | int:GAPDH |
| Interaction | FKBP6 interactions | 3.64e-04 | 86 | 79 | 4 | int:FKBP6 | |
| Interaction | DLG4 interactions | 3.73e-04 | 449 | 79 | 8 | int:DLG4 | |
| Interaction | LHPP interactions | 4.09e-04 | 37 | 79 | 3 | int:LHPP | |
| Interaction | RAD18 interactions | 4.20e-04 | 457 | 79 | 8 | int:RAD18 | |
| Interaction | PEA15 interactions | 4.33e-04 | 90 | 79 | 4 | int:PEA15 | |
| Interaction | DHX40 interactions | 4.38e-04 | 249 | 79 | 6 | int:DHX40 | |
| Interaction | EFTUD2 interactions | CEP170 ROCK2 GTPBP4 MYH10 SFPQ PAXBP1 EAPP SMC1A SPTBN1 MACF1 ATP1A1 DCTN1 THRAP3 SLX4 GOLGA4 | 4.48e-04 | 1449 | 79 | 15 | int:EFTUD2 |
| Interaction | IFI16 interactions | CEP170 GTPBP4 SNRNP27 SFPQ SLC4A1AP SYNE1 SMARCA1 HEATR5B ESF1 NGDN | 4.64e-04 | 714 | 79 | 10 | int:IFI16 |
| Interaction | KLF9 interactions | 4.90e-04 | 93 | 79 | 4 | int:KLF9 | |
| Interaction | YWHAZ interactions | DAB2IP CEP170 BDP1 FSIP2 MYH10 SFPQ SMC1A SPTBN1 MACF1 ATP1A1 MAPKAPK5 DCTN1 ERBIN WNK2 | 5.56e-04 | 1319 | 79 | 14 | int:YWHAZ |
| Interaction | HSPB8 interactions | 5.78e-04 | 172 | 79 | 5 | int:HSPB8 | |
| Interaction | WNK2 interactions | 5.96e-04 | 42 | 79 | 3 | int:WNK2 | |
| Interaction | AKAP17A interactions | 6.21e-04 | 99 | 79 | 4 | int:AKAP17A | |
| Interaction | RAD50 interactions | 6.29e-04 | 371 | 79 | 7 | int:RAD50 | |
| Interaction | MEN1 interactions | ZNF462 GTPBP4 MYH10 SFPQ PAXBP1 ZNF608 SMC1A DCTN1 SAP130 ERBIN THRAP3 NOL8 | 6.37e-04 | 1029 | 79 | 12 | int:MEN1 |
| Interaction | TEAD1 interactions | 6.42e-04 | 176 | 79 | 5 | int:TEAD1 | |
| Interaction | MYH7 interactions | 6.69e-04 | 101 | 79 | 4 | int:MYH7 | |
| Interaction | EFNA1 interactions | 7.21e-04 | 103 | 79 | 4 | int:EFNA1 | |
| Interaction | CSNK1A1 interactions | 7.36e-04 | 381 | 79 | 7 | int:CSNK1A1 | |
| Interaction | PPP1R9B interactions | ROCK2 MYH4 ATP6V1C1 MYH10 SPTBN1 FASTKD2 SNAP25 ATP1A1 DCTN1 | 7.54e-04 | 626 | 79 | 9 | int:PPP1R9B |
| Interaction | WDR76 interactions | 7.59e-04 | 383 | 79 | 7 | int:WDR76 | |
| Interaction | TRIM37 interactions | 7.89e-04 | 630 | 79 | 9 | int:TRIM37 | |
| Interaction | SNRPN interactions | 8.23e-04 | 186 | 79 | 5 | int:SNRPN | |
| Interaction | NTHL1 interactions | 8.30e-04 | 47 | 79 | 3 | int:NTHL1 | |
| Interaction | APC interactions | 8.31e-04 | 389 | 79 | 7 | int:APC | |
| Interaction | FBXW7 interactions | DAB2IP CEP170 GTPBP4 MYH10 SFPQ SMC1A SPTBN1 SMARCA1 MACF1 XRCC4 DCTN1 ZEB2 THRAP3 | 8.33e-04 | 1215 | 79 | 13 | int:FBXW7 |
| Interaction | MTA1 interactions | 8.57e-04 | 283 | 79 | 6 | int:MTA1 | |
| Cytoband | 17p13.1 | 1.99e-06 | 118 | 79 | 5 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 2.37e-06 | 346 | 79 | 7 | chr17p13 | |
| GeneFamily | Myosin heavy chains | 4.63e-20 | 15 | 54 | 9 | 1098 | |
| GeneFamily | EF-hand domain containing | 4.69e-05 | 219 | 54 | 6 | 863 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.82e-04 | 7 | 54 | 2 | 1113 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.31e-04 | 53 | 54 | 3 | 532 | |
| GeneFamily | Dyneins, axonemal | 1.16e-03 | 17 | 54 | 2 | 536 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 3.85e-03 | 31 | 54 | 2 | 81 | |
| GeneFamily | Ubiquitin specific peptidases | 1.22e-02 | 56 | 54 | 2 | 366 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 3.57e-07 | 20 | 79 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 4.40e-07 | 21 | 79 | 4 | MM1102 | |
| Coexpression | HALLMARK_MYOGENESIS | 2.47e-06 | 200 | 79 | 7 | M5909 | |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 1.34e-05 | 48 | 79 | 4 | M16123 | |
| Coexpression | DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS | 2.70e-05 | 194 | 79 | 6 | M40093 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CEP170 TCEA1 BDP1 MYH10 SLC4A1AP ZNF407 SNAP25 XRCC4 GOLGA4 ESF1 | 2.74e-05 | 656 | 79 | 10 | M18979 |
| Coexpression | GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN | 3.03e-05 | 198 | 79 | 6 | M5084 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 3.09e-05 | 295 | 79 | 7 | M39121 | |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN | 3.11e-05 | 199 | 79 | 6 | M6365 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 9.80e-05 | 152 | 79 | 5 | M2964 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.07e-04 | 81 | 79 | 4 | M39253 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ROCK2 ZNF462 HMGN5 SNRNP27 MYH10 SFPQ MYH7B ASPN SMC1A VCAN MLH1 MACF1 FASTKD2 MAPKAPK5 ERBIN THRAP3 ESF1 NOL8 FILIP1L | 7.97e-08 | 1241 | 78 | 19 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ROCK2 ZNF462 SPTBN4 TCEA1 BDP1 HMGN5 MYH10 PAXBP1 DNAH10 SYNE1 SMC1A MACF1 RASEF HEATR5B OGA ESF1 FILIP1L | 8.53e-08 | 989 | 78 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ROCK2 ZNF462 S100A5 HMGN5 SNRNP27 MYH10 SFPQ MYH7B ASPN SMC1A VCAN MLH1 MACF1 FASTKD2 MAPKAPK5 ERBIN THRAP3 ESF1 NOL8 FILIP1L | 2.25e-07 | 1468 | 78 | 20 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CEP170 TCEA1 MYH10 EAPP SMC1A USP32 MACF1 ZNF407 OGA SAP130 WNK3 GOLGA4 ESF1 | 2.39e-07 | 595 | 78 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CEP170 ROCK2 TCEA1 BDP1 HMGN5 MYH10 EAPP SMC1A MACF1 ZNF407 HEATR5B OGA ESF1 | 4.50e-07 | 629 | 78 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ROCK2 TCEA1 BDP1 HMGN5 MYH10 SYNE1 SMC1A MACF1 HEATR5B ESF1 FILIP1L | 4.98e-07 | 432 | 78 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | CEP170 TCEA1 BDP1 GTPBP4 EAPP SMC1A MLH1 MACF1 ZNF407 HEATR5B OGA ESF1 | 9.66e-07 | 564 | 78 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ROCK2 ZNF462 BDP1 HMGN5 CAAP1 MYH10 SFPQ ZBED4 SLC4A1AP SMC1A MLH1 MACF1 THRAP3 WNK3 ESF1 AKAP7 NOL8 | 2.43e-06 | 1257 | 78 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ROCK2 ZNF462 BDP1 HMGN5 CAAP1 MYH10 SFPQ ZBED4 SLC4A1AP SMC1A MLH1 MACF1 SNAP25 THRAP3 WNK3 ESF1 AKAP7 NOL8 | 4.24e-06 | 1459 | 78 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | skeletal muscle | 2.29e-05 | 320 | 78 | 8 | skeletal muscle | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.45e-05 | 532 | 78 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.90e-05 | 48 | 78 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.26e-05 | 105 | 78 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.48e-05 | 469 | 78 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 5.54e-05 | 266 | 78 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.16e-05 | 185 | 78 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.56e-05 | 192 | 78 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | ZNF462 SPTBN4 BDP1 SFPQ DNAH10 MACF1 FASTKD2 MAPKAPK5 FILIP1L | 7.91e-05 | 492 | 78 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.40e-05 | 124 | 78 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.72e-05 | 291 | 78 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.03e-04 | 203 | 78 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.45e-04 | 136 | 78 | 5 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.47e-04 | 311 | 78 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ROCK2 ZNF462 HMGN5 MYH10 SFPQ ZBED4 SMC1A VCAN MLH1 THRAP3 WNK3 ESF1 AKAP7 FILIP1L | 1.68e-04 | 1252 | 78 | 14 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_200 | 1.98e-04 | 6 | 78 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_100 | 2.16e-04 | 80 | 78 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_100 | 2.85e-04 | 86 | 78 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_100_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_200 | 3.18e-04 | 161 | 78 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_200_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_200 | 3.27e-04 | 162 | 78 | 5 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 3.53e-04 | 255 | 78 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#4_top-relative-expression-ranked_100 | 3.68e-04 | 8 | 78 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 4.45e-04 | 492 | 78 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 4.82e-04 | 498 | 78 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | PIKFYVE BDP1 HMGN5 SLC4A1AP SMC1A SMARCA1 MACF1 HEATR5B ERBIN SLX4 | 5.56e-04 | 780 | 78 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | DAB2IP ZNF462 SFPQ ASPN SMC1A SPTBN1 SNAP25 ZEB2 THRAP3 ESF1 | 6.14e-04 | 790 | 78 | 10 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.00e-04 | 298 | 78 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | ZNF462 TCEA1 ATP6V1C1 PAXBP1 SMC1A MACF1 ZNF407 SNAP25 HEATR5B OGA WNK2 | 8.69e-04 | 979 | 78 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 BDP1 GTPBP4 CAAP1 SLC4A1AP SMC1A SLX4 GOLGA4 ESF1 NOL8 | 9.04e-04 | 831 | 78 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 9.32e-04 | 204 | 78 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ROCK2 BDP1 HMGN5 GTPBP4 CAAP1 SMC1A SNAP25 GOLGA4 WNK2 ESF1 NOL8 | 9.44e-04 | 989 | 78 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 9.47e-04 | 836 | 78 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_500 | 1.01e-03 | 13 | 78 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_100 | 1.01e-03 | 13 | 78 | 2 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_100 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-11 | 184 | 79 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-08 | 182 | 79 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-08 | 185 | 79 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.81e-08 | 190 | 79 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.54e-08 | 194 | 79 | 7 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.60e-08 | 199 | 79 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.78e-08 | 62 | 79 | 5 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.78e-08 | 62 | 79 | 5 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.63e-07 | 77 | 79 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-07 | 176 | 79 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.06e-07 | 183 | 79 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 9.35e-07 | 184 | 79 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 191 | 79 | 6 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.24e-06 | 193 | 79 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 194 | 79 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.43e-06 | 198 | 79 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.48e-06 | 199 | 79 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.48e-06 | 199 | 79 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.52e-06 | 200 | 79 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.52e-06 | 200 | 79 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.88e-06 | 157 | 79 | 5 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-05 | 169 | 79 | 5 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 175 | 79 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.54e-05 | 176 | 79 | 5 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.63e-05 | 178 | 79 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 178 | 79 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.67e-05 | 179 | 79 | 5 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.81e-05 | 182 | 79 | 5 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.01e-05 | 186 | 79 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.07e-05 | 187 | 79 | 5 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.23e-05 | 190 | 79 | 5 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.29e-05 | 191 | 79 | 5 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 191 | 79 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.29e-05 | 191 | 79 | 5 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-05 | 191 | 79 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 191 | 79 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 191 | 79 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.34e-05 | 192 | 79 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 192 | 79 | 5 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 192 | 79 | 5 | 8171a60df481195c39a7f740effcae8e4deb6ca7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 192 | 79 | 5 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.34e-05 | 192 | 79 | 5 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 79 | 5 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 79 | 5 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 79 | 5 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 79 | 5 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 194 | 79 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.46e-05 | 194 | 79 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 195 | 79 | 5 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 195 | 79 | 5 | 598b69032a8441a23749b27863d80f7a1fc82a96 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.52e-05 | 195 | 79 | 5 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-05 | 195 | 79 | 5 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 195 | 79 | 5 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.52e-05 | 195 | 79 | 5 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-05 | 195 | 79 | 5 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 195 | 79 | 5 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 195 | 79 | 5 | 8aa753934debffe5ae4b5eecb6b50c46d17cc3ec | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-05 | 195 | 79 | 5 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 195 | 79 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-05 | 196 | 79 | 5 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.59e-05 | 196 | 79 | 5 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-05 | 196 | 79 | 5 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-05 | 196 | 79 | 5 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-05 | 196 | 79 | 5 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-05 | 196 | 79 | 5 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-05 | 196 | 79 | 5 | 2a885eed52f9b002c7995e11e450c7e8d7ae69e6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 2.59e-05 | 196 | 79 | 5 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-05 | 196 | 79 | 5 | 14246f00c90741a5f8683f377e22e3a7c99661b9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 196 | 79 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | PND07-Mesenchymal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-05 | 196 | 79 | 5 | 0050c7134473fbfd7b9f0ae8d6d337713e60b57d | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.65e-05 | 197 | 79 | 5 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-05 | 197 | 79 | 5 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 197 | 79 | 5 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-05 | 197 | 79 | 5 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-05 | 197 | 79 | 5 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.65e-05 | 197 | 79 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.65e-05 | 197 | 79 | 5 | 44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 197 | 79 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.65e-05 | 197 | 79 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 197 | 79 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-05 | 198 | 79 | 5 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.72e-05 | 198 | 79 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-05 | 198 | 79 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-05 | 198 | 79 | 5 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-05 | 198 | 79 | 5 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-05 | 198 | 79 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.78e-05 | 199 | 79 | 5 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.78e-05 | 199 | 79 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Epithelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-05 | 199 | 79 | 5 | bbe69e44b7970f57628365ae771790f2b13d0cae | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-05 | 199 | 79 | 5 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | 18-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 2.78e-05 | 199 | 79 | 5 | d65150d2e24c40aa82712e7f034f6772102bd293 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.78e-05 | 199 | 79 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | E16.5-Mesenchymal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-05 | 199 | 79 | 5 | ebd9ca151434f5ca27a82d4f1815a1ea500c1989 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.78e-05 | 199 | 79 | 5 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 2.78e-05 | 199 | 79 | 5 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.85e-05 | 200 | 79 | 5 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.13e-07 | 50 | 63 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.20e-06 | 49 | 63 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes in the cancer module 201. | 1.02e-05 | 50 | 63 | 5 | MODULE_201 | |
| Computational | Genes in the cancer module 387. | 1.86e-04 | 49 | 63 | 4 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 2.18e-04 | 51 | 63 | 4 | MODULE_329 | |
| Computational | Neighborhood of TTN | 4.53e-04 | 26 | 63 | 3 | GNF2_TTN | |
| Drug | fast white | 1.64e-14 | 42 | 78 | 9 | CID000024008 | |
| Drug | formycin triphosphate | 1.09e-13 | 51 | 78 | 9 | CID000122274 | |
| Drug | oxovanadium | 3.16e-13 | 120 | 78 | 11 | CID000024411 | |
| Drug | purealin | 3.75e-13 | 58 | 78 | 9 | CID006419303 | |
| Drug | NSC339663 | ROCK2 PIKFYVE MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B SYNE1 SNAP25 | 2.89e-12 | 250 | 78 | 13 | CID000003892 |
| Drug | blebbistatin | 7.47e-12 | 116 | 78 | 10 | CID003476986 | |
| Drug | B0683 | 8.15e-12 | 117 | 78 | 10 | CID006398969 | |
| Drug | SM-2 | 1.67e-11 | 87 | 78 | 9 | CID000486033 | |
| Drug | S-(-)-Etomoxir | 5.98e-11 | 100 | 78 | 9 | CID000060765 | |
| Drug | 4-chloroaniline | 9.45e-11 | 202 | 78 | 11 | CID000007812 | |
| Drug | 2bq7 | 3.88e-10 | 123 | 78 | 9 | CID006540267 | |
| Drug | AC1LADJ6 | 6.38e-10 | 130 | 78 | 9 | CID000486032 | |
| Drug | AC1NRBPQ | 1.02e-09 | 137 | 78 | 9 | CID005288569 | |
| Drug | creatine | 1.16e-09 | 193 | 78 | 10 | CID000000586 | |
| Drug | clenbuterol | 1.40e-09 | 142 | 78 | 9 | CID000002783 | |
| Drug | candesartan cilexetil | 1.68e-09 | 145 | 78 | 9 | CID000002540 | |
| Drug | AC1N9ZZC | 2.14e-09 | 149 | 78 | 9 | CID004369374 | |
| Drug | MgCl2 | SPTBN4 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B SPTBN1 OGA | 2.87e-09 | 354 | 78 | 12 | CID000024584 |
| Drug | carvedilol | 4.24e-09 | 161 | 78 | 9 | CID000002585 | |
| Drug | AC1L1IZ2 | 7.06e-09 | 304 | 78 | 11 | CID000004795 | |
| Drug | K-Cl | ROCK2 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B SNAP25 ATP1A1 ZEB2 RYR1 | 7.13e-09 | 567 | 78 | 14 | CID000004873 |
| Drug | trifluoperazine | SPTBN4 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B SPTBN1 | 1.36e-08 | 324 | 78 | 11 | CID000005566 |
| Drug | N-ethylmaleimide | SPTBN4 MYH1 MYH2 MYH3 MYH4 ATP6V1C1 MYH7 MYH8 MYH10 MYH13 MYH7B SPTBN1 SNAP25 | 1.84e-08 | 511 | 78 | 13 | CID000004362 |
| Drug | NSC611747 | 3.19e-08 | 352 | 78 | 11 | CID000002534 | |
| Drug | NSC226080 | ROCK2 PIKFYVE MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B VCAN FGFR4 XRCC4 RYR1 | 5.57e-08 | 782 | 78 | 15 | CID000005040 |
| Drug | 4-epidoxorubicin | ROCK2 PIKFYVE MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B VCAN SPTBN1 MLH1 XRCC4 | 6.15e-08 | 788 | 78 | 15 | CID000001690 |
| Drug | nocodazole | ROCK2 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B DCTN1 GOLGA4 | 7.73e-08 | 477 | 78 | 12 | CID000004122 |
| Drug | NSC107658 | 9.32e-08 | 306 | 78 | 10 | CID000002919 | |
| Drug | verapamil | MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B SCN5A ATP1A1 RYR1 | 1.03e-07 | 490 | 78 | 12 | CID000002520 |
| Drug | nifedipine | 1.68e-07 | 415 | 78 | 11 | CID000004485 | |
| Drug | isoproterenol | S100A5 MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B VCAN SCN5A RYR1 | 4.13e-07 | 669 | 78 | 13 | CID000003779 |
| Drug | eye gene | 5.24e-07 | 369 | 78 | 10 | CID000004782 | |
| Drug | D-triiodothyronine | 1.33e-06 | 409 | 78 | 10 | CID000000861 | |
| Drug | Spermine | 2.49e-06 | 63 | 78 | 5 | ctd:D013096 | |
| Drug | wartmannin | ROCK2 PIKFYVE MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B MLH1 XRCC4 | 3.51e-06 | 811 | 78 | 13 | CID000005691 |
| Drug | carbachol | ROCK2 PIKFYVE MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B RYR1 | 3.69e-06 | 688 | 78 | 12 | CID000002551 |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; PC3; HT_HG-U133A | 5.13e-06 | 197 | 78 | 7 | 6726_UP | |
| Drug | Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 5.30e-06 | 198 | 78 | 7 | 4145_UP | |
| Drug | cefditoren | 1.08e-05 | 13 | 78 | 3 | CID000444006 | |
| Drug | pyrophosphate | 1.37e-05 | 654 | 78 | 11 | CID000001023 | |
| Drug | Botulinum Toxins, Type A | 2.10e-05 | 16 | 78 | 3 | ctd:D019274 | |
| Drug | NSC-114340 | 2.10e-05 | 16 | 78 | 3 | CID000004598 | |
| Drug | NSC9700 | 2.75e-05 | 578 | 78 | 10 | CID000005408 | |
| Drug | NSC-381858 | 3.47e-05 | 3 | 78 | 2 | CID000343067 | |
| Drug | LY294002 | ROCK2 PIKFYVE MYH1 MYH2 MYH3 MYH4 MYH7 MYH8 MYH10 MYH13 MYH7B | 4.69e-05 | 748 | 78 | 11 | CID000003973 |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A | 4.87e-05 | 190 | 78 | 6 | 6718_DN | |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A | 6.12e-05 | 198 | 78 | 6 | 6238_UP | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 6.29e-05 | 199 | 78 | 6 | 6515_UP | |
| Drug | Ca21 | 1.15e-04 | 5 | 78 | 2 | CID010245508 | |
| Drug | C 5319 | 1.15e-04 | 5 | 78 | 2 | CID000054040 | |
| Drug | NSC 523214 | 1.51e-04 | 147 | 78 | 5 | CID000004752 | |
| Drug | nojirimycin 6-phosphate | 1.72e-04 | 6 | 78 | 2 | CID000195171 | |
| Drug | 2alpha-propoxy-1alpha,25-dihydroxyvitamin D3 | 1.72e-04 | 6 | 78 | 2 | CID010062706 | |
| Drug | chrysene | ROCK2 HMGN5 MYH1 MYH4 SMC1A RASGRP3 SPTBN1 OGA THRAP3 RYR1 AKAP7 | 1.80e-04 | 871 | 78 | 11 | ctd:C031180 |
| Drug | plakin | 1.82e-04 | 82 | 78 | 4 | CID000018752 | |
| Drug | 1-adamantanecarboxylic acid | 2.41e-04 | 7 | 78 | 2 | CID000013235 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 5.93e-20 | 10 | 76 | 8 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 6.50e-19 | 12 | 76 | 8 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 6.50e-19 | 12 | 76 | 8 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.69e-18 | 13 | 76 | 8 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.40e-18 | 15 | 76 | 8 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 4.60e-13 | 48 | 76 | 8 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.24e-11 | 71 | 76 | 8 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.31e-11 | 80 | 76 | 8 | DOID:12930 (implicated_via_orthology) | |
| Disease | Multiple pterygium syndrome | 3.92e-05 | 4 | 76 | 2 | C0265261 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 3.92e-05 | 4 | 76 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 3.92e-05 | 4 | 76 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 5.29e-05 | 156 | 76 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 5.29e-05 | 156 | 76 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 5.29e-05 | 156 | 76 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 5.96e-05 | 160 | 76 | 5 | C0004238 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 9.75e-05 | 6 | 76 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | Lissencephaly | 9.75e-05 | 6 | 76 | 2 | C0266463 | |
| Disease | Congenital myopathy with fiber type disproportion | 9.75e-05 | 6 | 76 | 2 | cv:C0546264 | |
| Disease | Adenoid Cystic Carcinoma | 1.32e-04 | 100 | 76 | 4 | C0010606 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.36e-04 | 7 | 76 | 2 | C0751337 | |
| Disease | QRS-T angle | 1.65e-04 | 106 | 76 | 4 | EFO_0020097 | |
| Disease | subiculum volume | 1.88e-04 | 43 | 76 | 3 | EFO_0009399 | |
| Disease | multiple sclerosis symptom measurement | 2.30e-04 | 46 | 76 | 3 | EFO_0803536 | |
| Disease | Distal arthrogryposis | 2.33e-04 | 9 | 76 | 2 | cv:C0265213 | |
| Disease | neuroimaging measurement | ZNF462 MYH10 RASGRP3 VCAN SPTBN1 MACF1 XRCC4 QSOX2 WNK2 PGM1 | 4.08e-04 | 1069 | 76 | 10 | EFO_0004346 |
| Disease | Autosomal Dominant Myotubular Myopathy | 5.01e-04 | 13 | 76 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 5.01e-04 | 13 | 76 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 5.01e-04 | 13 | 76 | 2 | C0410203 | |
| Disease | Congenital Structural Myopathy | 5.01e-04 | 13 | 76 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, 1 | 5.01e-04 | 13 | 76 | 2 | C4551952 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 5.84e-04 | 14 | 76 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 5.84e-04 | 14 | 76 | 2 | C0410207 | |
| Disease | Left ventricular noncompaction | 5.84e-04 | 14 | 76 | 2 | C1960469 | |
| Disease | insulin measurement | 6.39e-04 | 267 | 76 | 5 | EFO_0004467 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 6.73e-04 | 15 | 76 | 2 | C3645536 | |
| Disease | Congenital Fiber Type Disproportion | 9.75e-04 | 18 | 76 | 2 | C0546264 | |
| Disease | Prostatic Neoplasms | 1.05e-03 | 616 | 76 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.05e-03 | 616 | 76 | 7 | C0376358 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 1.09e-03 | 19 | 76 | 2 | C1333991 | |
| Disease | response to methotrexate, neurotoxicity | 1.09e-03 | 19 | 76 | 2 | EFO_0011057, GO_0031427 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 1.46e-03 | 22 | 76 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | PR interval | 1.75e-03 | 495 | 76 | 6 | EFO_0004462 | |
| Disease | Myocardial Infarction | 1.92e-03 | 95 | 76 | 3 | C0027051 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.04e-03 | 26 | 76 | 2 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.20e-03 | 27 | 76 | 2 | C1112155 | |
| Disease | congestive heart failure (is_implicated_in) | 2.20e-03 | 27 | 76 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 2.54e-03 | 29 | 76 | 2 | C1333990 | |
| Disease | cardiovascular age measurement | 2.54e-03 | 29 | 76 | 2 | EFO_0803380 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EALKSEEKAMDISAM | 156 | Q5SW79 | |
| EESEELSSDEEMKMA | 596 | Q96RT1 | |
| KMAVVEEMEADLKET | 1271 | A6H8Y1 | |
| DDKEMKEEDTSLVNM | 2166 | P13611 | |
| MATLDKEMAEERAES | 306 | Q14203 | |
| KKMSEEFEANTMDSL | 21 | Q9P0M2 | |
| QEATFEEMEKLVKDM | 56 | P43652 | |
| EKEMRSLGVDMDDKD | 521 | Q9BZE4 | |
| DKDLADLVSEMEVMK | 511 | P22455 | |
| AEEMDVALSDKDMEI | 141 | Q8NB90 | |
| EAELNSTMKTMEDKL | 66 | Q56P03 | |
| MDSDMEEEADDGSKM | 201 | Q9H8G2 | |
| VEAEQMMKEADKDGD | 146 | Q8TD86 | |
| LKNMMLKDMEDTDDD | 26 | Q9BXN1 | |
| EEVEAEGANKMMKDL | 431 | P36871 | |
| DKAAMQLSELEEEMD | 196 | Q8IZ41 | |
| EHFEEMAKESMDSVK | 481 | Q6ZRP7 | |
| KSAEREKEMASMKEE | 841 | P12883 | |
| DAAMMAEELKKEQDT | 1761 | P12883 | |
| LMSVEEELKKDHAEM | 1106 | Q5VWQ8 | |
| SDDQDFLDSKDTMKM | 6 | Q6ZST4 | |
| MSEESDMDKAIKETS | 1 | Q8IW41 | |
| DCLKGEMEDDKSKME | 1496 | Q13439 | |
| DMDELKKEVSMDDHK | 31 | P05023 | |
| EDSKKNEMAELDIMG | 5296 | Q5CZC0 | |
| AEMALLMMDEDEDSK | 706 | Q9H501 | |
| AAMMAEELKKEQDTS | 1811 | A7E2Y1 | |
| AETEKEMATMKEEFQ | 846 | P13535 | |
| EMATMKEEFQKTKDE | 851 | P13535 | |
| AMMAEELKKEQDTSA | 1766 | P13535 | |
| EKSEMKMEIDDLASN | 1226 | Q9UKX2 | |
| TDAAMMAEELKKEQD | 1766 | Q9UKX2 | |
| KTKSDMMEENIDTSA | 46 | P82970 | |
| LSISMEEEDDMKIDE | 331 | Q96JB8 | |
| SAETEKEMANMKEEF | 846 | P12882 | |
| AAMMAEELKKEQDTS | 1766 | P12882 | |
| DTDSEDELRMMIAKE | 301 | Q76FK4 | |
| EMDMESEKEEEKPKT | 186 | Q9Y5B6 | |
| LESKEEVLKSMDAMS | 4481 | Q9UPN3 | |
| KMEDIFAQKEMEEGE | 1446 | Q9Y2I7 | |
| AEKKDEMDDDTMFTT | 1216 | Q9P2D3 | |
| EMEMESKEKKPSESD | 216 | Q8TD57 | |
| DMEGKDEELIKMEEQ | 381 | Q4L180 | |
| DMKAIEDDLMKTEDE | 641 | Q4L180 | |
| TKEAISEATDMKEAM | 106 | Q8IVF4 | |
| KSEDEDEPDMKCDDM | 4866 | P21817 | |
| ADMEDLMSSKDDVGK | 1511 | P35580 | |
| EEMKADKEEMNRLST | 256 | P21283 | |
| EKEMDPEYEEKMKAD | 76 | P28370 | |
| EDTLEEDIKTMEMVK | 1431 | Q8NF91 | |
| KMAEELKPMDTDKES | 491 | O60502 | |
| TEEVDMKEMEKALQE | 531 | Q06033 | |
| EMDKLEMEDAVTFLK | 676 | Q9NYY8 | |
| LDKDQDGLISKDEMM | 461 | Q8IV61 | |
| EDLEGKTEEEIEMMK | 91 | Q8WVK2 | |
| ETEEKEKRFQEAMEM | 426 | Q14524 | |
| SAETEKEMANMKEEF | 846 | Q9Y623 | |
| AAMMAEELKKEQDTS | 1766 | Q9Y623 | |
| TDAAMMAEELKKEQD | 1761 | P11055 | |
| ARMTAEEMASDELKE | 221 | P23193 | |
| DSDVEMVEDDSRKEM | 476 | P40692 | |
| ESLKTGQMMDESDED | 36 | Q8IY92 | |
| EEGMDQINKDMKEAE | 61 | P60880 | |
| MSEEKAKDEQSAVSM | 1616 | Q01082 | |
| IMDKEETKVSEDDEM | 761 | G9CGD6 | |
| NMKDAKDKLESEMED | 511 | P23246 | |
| DDFEKKMADFHKEEM | 416 | Q9Y2W1 | |
| NMMSKLSSEDEEEDE | 136 | Q8NEJ9 | |
| EEGDMMETNSTDDEK | 846 | Q9H0E3 | |
| EISQEADDMAMEKGK | 51 | Q13426 | |
| SAEAEKEMATMKEDF | 846 | Q9UKX3 | |
| KEMATMKEDFERTKE | 851 | Q9UKX3 | |
| AAMMAEELKKEQDTS | 1766 | Q9UKX3 | |
| FTDLEKEKSNMEIDM | 676 | O75116 | |
| GDMDELEKEMLSVEK | 331 | Q14683 | |
| ELLMMSEDKGKDEQS | 1641 | Q9H254 | |
| DVTECKMDDDEEMKN | 1906 | O00507 | |
| EAEEMDEETKRKKMT | 131 | Q9HBF4 | |
| MGNSMLVKKEEEEEE | 276 | Q9ULD9 | |
| MKEKMESSSSDDEDK | 2371 | Q96JM2 | |
| EMKESSIDDLMKSLD | 46 | P33763 | |
| MMDSENKPENDEDEK | 1 | Q9C0G0 | |
| KDVMDKAEDMLSEDT | 1251 | Q9Y3S1 | |
| GMLAMDDKKDNEAEI | 676 | Q6ZXV5 | |
| DGKMETKSDHEEDNM | 1196 | O60315 | |
| MESEDTKKTQEMKTD | 1 | Q8NA31 | |
| KKMADTSSMDEDFES | 1581 | Q8NFA0 | |
| SLERMDFKSEQEDMK | 36 | O75132 | |
| FKEKNEKEMEEEAEM | 121 | Q9BYP7 | |
| EKEMEEEAEMKAVAT | 126 | Q9BYP7 | |
| KMLGEDSDEEEEMDT | 306 | Q9BWU0 |